Nadine Houede

BAG6 promotes PINK1 signaling pathway and is essential for mitophagy.

Authors:

Romain Ragimbeau Leila El Kebriti Salwa Sebti Elise Fourgous Abdelhay Boulahtouf Giuseppe Arena Lucile Espert Andrei Turtoi Céline Gongora Nadine Houédé Sophie Pattingre

FASEB J 2021 Feb;35(2):e21361

IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France.

View Article and Find Full Text PDF

February 2021

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial.

Target Oncol 2021 Jan;16(1):47-57

Clinical Research Unit, Institut Universitaire du Cancer, Oncopole, Toulouse, France.

View Article and Find Full Text PDF

January 2021

Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors.

Authors:

Jean-Pierre Delord Antoine Italiano Ahmad Awada Philippe Aftimos Nadine Houédé Céleste Lebbé Celine Pages Thierry Lesimple Monica Dinulescu Jan H M Schellens Suzanne Leijen Sylvie Rottey Vibeke Kruse Richard Kefford Sandrine Faivre Carlos Gomez-Roca Armin Scheuler Giorgio Massimini Eric Raymond

Target Oncol 2021 Jan;16(1):37-46

Paris Diderot University Hospital, Clichy, France.

View Article and Find Full Text PDF

January 2021

Feasibility and efficacy of a supervised home-based physical exercise program for metastatic cancer patients receiving oral targeted therapy: study protocol for the phase II/III - UNICANCER SdS 01 QUALIOR trial.

Authors:

Florence Joly Claudia Lefeuvre-Plesse Claire Garnier-Tixidre Carole Helissey Nathalie Menneveau Alain Zannetti Sebastien Salas Nadine Houede Sophie Abadie-Lacourtoisie Laetitia Stefani Soazig Nenan Isabelle Rieger Isabelle Durand-Zaleski Jean-Marc Descotes Amélie Anota

BMC Cancer 2020 Oct 9;20(1):975. Epub 2020 Oct 9.

CHRU de Besançon, Besançon, France.

View Article and Find Full Text PDF

October 2020

Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors.

Eur Urol 2020 12 15;78(6):822-830. Epub 2020 Aug 15.

The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

December 2020

Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study.

Authors:

Nadine Houédé Xavier Rébillard Sophie Bouvet Sarah Kabani Pascale Fabbro-Peray Brigitte Trétarre Florence Ménégaux

BMC Cancer 2020 Aug 12;20(1):757. Epub 2020 Aug 12.

Center for Research in Epidemiology and Population Health, INSERM U1018, Villejuif, France.

View Article and Find Full Text PDF

August 2020

PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatment.

Authors:

Mathieu Roumiguié Eva Compérat Léonor Chaltiel François Xavier Nouhaud Gregory Verhoest Alexandra Masson-Lecomte Pierre Colin François Audenet Nadine Houédé Stéphane Larré Evanguelos Xylinas Serge Brunelle Jeanne Piana-Thomassin Juliette Cotte Géraldine Pignot Yann Neuzillet Morgan Rouprêt

World J Urol 2020 Jul 14. Epub 2020 Jul 14.

Urology Department, GRC n°5, PREDICTIVE ONCO-URO, AP-HP, Hôpital Pitié-Salpêtrière, Sorbonne University, 75013, Paris, France.

View Article and Find Full Text PDF

July 2020

Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group.

Clin Genitourin Cancer 2020 08 5;18(4):295-303.e3. Epub 2019 Dec 5.

Department of Medical Oncology, Hôpital Européen Georges Pompidou, Paris, France; Association pour la Recherche et les Thérapeutiques Innovantes en Cancérologie, Paris, France; University René Descartes, Paris, France.

View Article and Find Full Text PDF

August 2020

Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?

Authors:

Melissa Bersanelli Roberto Iacovelli Sebastiano Buti Nadine Houede Brigitte Laguerre Giuseppe Procopio Stéphanie Lheureux R Fischer Sylvie Negrier Alain Ravaud Stéphane Oudard Bernard Escudier Laurence Albiges Camillo Porta

Eur Urol Oncol 2019 Jul 19. Epub 2019 Jul 19.

Medical Oncology, IRCCS Policlinico San Matteo, Pavia, Italy.

View Article and Find Full Text PDF

July 2019

Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.

J Clin Oncol 2019 08 13;37(23):2008-2016. Epub 2019 Jun 13.

1Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.

View Article and Find Full Text PDF

August 2019

[Care of advanced or metastatic bladder cancer in second line: A specific place for vinflunine].

Authors:

Nadine Houédé Gérard Milano

Bull Cancer 2019 May 10;106(5):431-435. Epub 2019 Apr 10.

Centre Antoine-Lacassagne, 06200 Nice, France.

View Article and Find Full Text PDF

May 2019

Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.

JAMA Oncol 2019 May;5(5):623-632

Association pour la Recherche sur les Thérapeutiques Innovantes en Cancérologie, Paris, France.

View Article and Find Full Text PDF

May 2019

Clinical Relevance of Routine Monitoring of Patient-reported Outcomes Clinician-reported Outcomes in Oncology.

Authors:

Frederic Fiteni Alice Cuenant Mireille Favier Christelle Cousin Nadine Houede

In Vivo 2019 Jan-Feb;33(1):17-21

Department of Medical Oncology, University Hospital of Nimes, Nimes, France.

View Article and Find Full Text PDF

April 2019

Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study.

Clin Genitourin Cancer 2019 Feb 6;17(1):e38-e43. Epub 2018 Sep 6.

Institut Gustave Roussy, Villejuif, France.

View Article and Find Full Text PDF

February 2019

[Impacts of routine patient-reported-outcomes monitoring in oncology].

Authors:

Frédéric Fiteni Mireille Favier Caroline Bascoul-Mollevi Sophie Gourgou Christelle Cousin Nadine Houédé

Bull Cancer 2018 Sep 20;105(9):847-848. Epub 2018 Jul 20.

CHU de Nîmes, service d'oncologie médicale, 4, rue du Professeur-Robert-Debré, 30029 Nîmes, France; Université de Montpellier, 163, rue Auguste-Broussonnet, 34090 Montpellier, France; Université de Montpellier, Institut de recherche en cancérologie de Montpellier, Inserm U1194, Montpellier, France.

View Article and Find Full Text PDF

September 2018

Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways.

Authors:

Mathieu Rouanne Mathieu Roumiguié Nadine Houédé Alexandra Masson-Lecomte Pierre Colin Géraldine Pignot Stéphane Larré Evanguelos Xylinas Morgan Rouprêt Yann Neuzillet

World J Urol 2018 Nov 1;36(11):1727-1740. Epub 2018 Jun 1.

Department of Urology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, 40 Rue Worth, 92150, Suresnes, France.

View Article and Find Full Text PDF

November 2018

Enterocolitis in Patients with Cancer Treated with Docetaxel.

Authors:

Frédéric Fiteni Marie-Justine Paillard Emeline Orillard Loriane Lefebvre Sarah Nadjafizadeh Zohair Selmani Salim Benhamida Antoine Roland Antoine Baumann Angélique Vienot Nadine Houédé Xavier Pivot

Anticancer Res 2018 04;38(4):2443-2446

Department of Medical Oncology, University Hospital of Besançon, Besançon, France.

View Article and Find Full Text PDF

April 2018

Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer.

Authors:

Marina Pulido Guilhem Roubaud Anne-Laure Cazeau Hakim Mahammedi Lionel Vedrine Florence Joly Loic Mourey Christian Pfister Alejandro Goberna Barbara Lortal Carine Bellera Philippe Pourquier Nadine Houédé

BMC Cancer 2018 02 17;18(1):194. Epub 2018 Feb 17.

INSERM U1194, Montpellier Cancer Research Institute, Montpellier, France.

View Article and Find Full Text PDF

February 2018

LINE-1 as a therapeutic target for castration-resistant prostate cancer.

Authors:

Nadine Houede Pier Vincenzo Piazza Philippe Pourquier

Front Biosci (Landmark Ed) 2018 Jan 1;23:1292-1309. Epub 2018 Jan 1.

Medical Oncology Department, Nimes University Hospital, Nimes, and NSERM U1194, Montpellier Cancer Research Institute, and Montpellier University, France, philippe.pourquier@ inserm.fr.

View Article and Find Full Text PDF

January 2018

Radium 223 dichloride for prostate cancer treatment.

Authors:

Emmanuel Deshayes Mathieu Roumiguie Constance Thibault Philippe Beuzeboc Florent Cachin Christophe Hennequin Damien Huglo François Rozet Diana Kassab-Chahmi Xavier Rebillard Nadine Houédé

Drug Des Devel Ther 2017 6;11:2643-2651. Epub 2017 Sep 6.

Radiobiology Unit, INSERM U1194, Institut du Cancer de Montpellier (ICM).

View Article and Find Full Text PDF

June 2018

Prospective Evaluation of the Impact of Antiangiogenic Treatment on Cognitive Functions in Metastatic Renal Cancer.

Authors:

Florence Joly Natacha Heutte Brigitte Duclos Sabine Noal Isabelle Léger-Hardy Sarah Dauchy Nadine Longato Laurence Desrues Nadine Houede Marie Lange Emmanuel Sevin Chantal Rieux Bénédicte Clarisse Hélène Castel Bernard Escudier

Eur Urol Focus 2016 Dec 17;2(6):642-649. Epub 2016 May 17.

Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.

View Article and Find Full Text PDF

December 2016

Ductal adenocarcinoma of the prostate: Clinical and biological profiles.

Authors:

Armelle Vinceneux Franck Bruyère Olivier Haillot Thomas Charles Alexandre de la Taille Laurent Salomon Yves Allory Idir Ouzaid Laurence Choudat Morgan Rouprêt Eva Comperat Nadine Houede Jean-Baptiste Beauval Patrick Vourc'h Gaëlle Fromont

Prostate 2017 Sep 12;77(12):1242-1250. Epub 2017 Jul 12.

Department of Pathology, CHU de tours, Université François Rabelais, Tours, France.

View Article and Find Full Text PDF

September 2017

Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer.

Authors:

Litaty C Mbatchi Matthieu Gassiot Philippe Pourquier Alejando Goberna Hakim Mahammedi Loic Mourey Florence Joly Serge Lumbroso Alexandre Evrard Nadine Houede

Cancer Chemother Pharmacol 2017 Sep 4;80(3):653-659. Epub 2017 Jul 4.

IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, 34298, Montpellier, France.

View Article and Find Full Text PDF

September 2017

Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post Hoc Analysis of the Mainsail Study.

JAMA Oncol 2017 Jan;3(1):68-75

Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands.

View Article and Find Full Text PDF

January 2017

Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort.

Authors:

Damien Pouessel Sylvie Bastuji-Garin Nadine Houédé Dimitri Vordos Yohann Loriot Christine Chevreau Emmanuel Sevin Philippe Beuzeboc Alexandre de la Taille Aurélie Le Thuaut Yves Allory Stéphane Culine

Clin Genitourin Cancer 2017 02 21;15(1):e45-e52. Epub 2016 Jul 21.

Department of Medical Oncology, Hôpital Saint-Louis, AP-HP, Paris, France; Paris Diderot University, Paris, France.

View Article and Find Full Text PDF

February 2017

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.

J Clin Oncol 2016 09 11;34(25):3005-13. Epub 2016 Jul 11.

Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia.

View Article and Find Full Text PDF

September 2016